These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10088128)

  • 1. Expanded-capacity adenoviral vectors--the helper-dependent vectors.
    Morsy MA; Caskey CT
    Mol Med Today; 1999 Jan; 5(1):18-24. PubMed ID: 10088128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in helper-dependent adenoviral vector research.
    Segura MM; Alba R; Bosch A; Chillón M
    Curr Gene Ther; 2008 Aug; 8(4):222-35. PubMed ID: 18691018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helper-dependent adenoviral vectors for gene therapy.
    Palmer DJ; Ng P
    Hum Gene Ther; 2005 Jan; 16(1):1-16. PubMed ID: 15703484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral vectors for gene replacement therapy.
    Cao H; Koehler DR; Hu J
    Viral Immunol; 2004; 17(3):327-33. PubMed ID: 15357899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in helper-dependent adenoviral vector--a review review].
    Fu Y; He J; Shi C; Hong T
    Wei Sheng Wu Xue Bao; 2009 Feb; 49(2):147-52. PubMed ID: 19445167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity associated with repeated administration of first-generation adenovirus vectors does not occur with a helper-dependent vector.
    O'Neal WK; Zhou H; Morral N; Langston C; Parks RJ; Graham FL; Kochanek S; Beaudet AL
    Mol Med; 2000 Mar; 6(3):179-95. PubMed ID: 10965494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.
    Brunetti-Pierri N; Ng P
    Virus Genes; 2017 Oct; 53(5):684-691. PubMed ID: 28593513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy.
    Brunetti-Pierri N; Ng P
    Curr Opin Mol Ther; 2006 Oct; 8(5):446-54. PubMed ID: 17078387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
    Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
    Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved vascular gene transfer with a helper-dependent adenoviral vector.
    Wen S; Graf S; Massey PG; Dichek DA
    Circulation; 2004 Sep; 110(11):1484-91. PubMed ID: 15326058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper-dependent adenovirus for the gene therapy of proliferative retinopathies: stable gene transfer, regulated gene expression and therapeutic efficacy.
    Lamartina S; Cimino M; Roscilli G; Dammassa E; Lazzaro D; Rota R; Ciliberto G; Toniatti C
    J Gene Med; 2007 Oct; 9(10):862-74. PubMed ID: 17685494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
    Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
    Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-directed gene therapy with helper-dependent adenoviral vectors: current state of the art and future challenges.
    Vetrini F; Ng P
    Curr Pharm Des; 2011; 17(24):2488-99. PubMed ID: 21774769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress and prospects: gene therapy for genetic diseases with helper-dependent adenoviral vectors.
    Brunetti-Pierri N; Ng P
    Gene Ther; 2008 Apr; 15(8):553-60. PubMed ID: 18288209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune response to helper dependent adenoviral mediated liver gene therapy: challenges and prospects.
    Seiler MP; Cerullo V; Lee B
    Curr Gene Ther; 2007 Oct; 7(5):297-305. PubMed ID: 17979676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helper-dependent adenoviral vectors for liver-directed gene therapy.
    Brunetti-Pierri N; Ng P
    Hum Mol Genet; 2011 Apr; 20(R1):R7-13. PubMed ID: 21470977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helper-dependent adenoviral vectors in experimental gene therapy.
    Józkowicz A; Dulak J
    Acta Biochim Pol; 2005; 52(3):589-99. PubMed ID: 16082408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of helper-dependent adenoviral vectors.
    Ng P; Parks RJ; Graham FL
    Methods Mol Med; 2002; 69():371-88. PubMed ID: 11987790
    [No Abstract]   [Full Text] [Related]  

  • 19. Helper virus-free gutless adenovirus (HF-GLAd): a new platform for gene therapy.
    Liu J; Seol DW
    BMB Rep; 2020 Nov; 53(11):565-575. PubMed ID: 32958121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons.
    Morral N; O'Neal W; Rice K; Leland M; Kaplan J; Piedra PA; Zhou H; Parks RJ; Velji R; Aguilar-Córdova E; Wadsworth S; Graham FL; Kochanek S; Carey KD; Beaudet AL
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12816-21. PubMed ID: 10536005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.